The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms SSAT073
- 27 Oct 2017 Planned End Date changed from 1 Feb 2018 to 1 Aug 2018.
- 27 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Apr 2018.
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.